Based on our Pharmacor advisory service entitled Prostate Cancer, Decision Resources is offering an exclusive Pharmacor analyst call entitled Sanofi-Aventis’s Novel Agent Emerges as an Effective Treatment for Prostate Cancer: Which Current Drugs Will Lose Market Share to Cabazitaxel? Because this analyst call will feature major updates, it is ONLY available to purchasers of one or both of this Pharmacor advisory service.

 

This analyst call was held on January 15, 2010. Contact us to learn how you can purchase this Pharmacor advisory service and access a recorded playback of this event.

Click here to view the invite.